Eli Lilly and Co edged past Wall Street estimates for quarterly revenue on Tuesday, as higher sales of its top-selling diabetes drug, Trulicity, helped offset the impact of generic competition on its erectile dysfunction drug, Cialis.
A strong rise in oil and gas production helped BP offset weaker crude prices and refining profit to again beat profit expectations on Tuesday, boosting its shares.
Japan's Sony Corp surprised the market by reporting on Tuesday a record first-quarter operating profit despite the slowing gaming business, as strong demand for multiple-lens camera systems for smartphones boosted sales of image sensors.
"This headline is not good one for Capital One," says one analyst at RBC Capital Markets.
Procter & Gamble Co's quarterly revenue and profit beat Wall Street expectations on Tuesday, boosted by price hikes and strong demand for its beauty products such as SK-II and Olay, sending its shares up about 4% before the opening bell.
Independent oil and gas producer ConocoPhillips reported an 11.6% drop in quarterly profit on Tuesday, as fears of slowing global economy weighed on crude prices.
Beyond Meat shared tanked after the company announced a mixed earnings report and a secondary offering plan.
Sportswear maker Under Armour Inc on Tuesday cut its full-year revenue forecast for North America, its biggest market, in the face of stiff competition from bigger rivals Nike Inc and Adidas AG , sending its share down 10%.
Seven years ago, Diamondback Energy Inc went public with a modest parcel of drillable land in the Permian Basin of West Texas.
Eli Lilly and Co beat analysts' estimates for quarterly profit on Tuesday and raised its full-year earnings forecast, as higher sales of diabetes drugs Trulicity and Basaglar offset competition for its erectile dysfunction drug, Cialis.
Chinese tech giant Huawei Technologies warned on Tuesday a U.S. trade blacklisting will impact short-term revenue growth, even as its half-year revenue surged 23% thanks to soaring smartphone sales at home.
Merck & Co Inc reported higher-than-expected second-quarter profit on Tuesday, powered by strong demand for its cancer immunotherapy Keytruda and vaccines, sending its shares up 3% in early trading.
No.1 U.S. homebuilder D.R. Horton Inc beat Wall Street estimates for third-quarter profit and revenue on Tuesday, boosted by higher home sales and declining mortgage rates.
Xerox Inc cut its full-year revenue forecast on Tuesday, citing organizational changes, primarily in North America.
Goldman Sachs raises its 2019 year-end price target for the U.S. benchmark S&P 500 index by 3% to 3,100.